Alexander Chucholowski

This inventor holds 21 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Hoffmann-La Roche Inc., Chembridge Corporation, Sloan-Kettering Institute for Cancer Research. Active years: 2001-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Chucholowski. Retrieved from https://idiyas.com/inventor/alexander-chucholowski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 6)

% Patents Active = 14.3

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 7.8

ph-index = 6

Forward Citations = 167(Granted Patents)

Location History:

Grenzach-Wyhlen, DE (2001 - 2006)
San Deigo, CA (US) (2007)
San Diego, CA (US) (2003 - 2024)

Company Filing History:

16 out of 5,026

Hoffmann-La Roche Inc.

patents

3 out of 8

Chembridge Corporation

patents

1 out of 519

Sloan-Kettering Institute for Cancer Research

Years Active: 2001-2024

Loading Chart...

Areas of Expertise:

Drug-Conjugates

EGFR Inhibitors

KRAS Inhibitors

Tyrosine Kinase Inhibitors

Heterocyclic Compounds

Neoplastic Diseases

Inflammatory Disorders

Immunomodulatory Disorders

Benzimidazole Derivatives

Pyrrolidine Derivatives

Dihydroindole Derivatives

Tetrahydroquinoline Derivatives

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11987622 - Drug-conjugates with a targeting molecule and two different drugs (2024-05-21),

2. 9562019 - Substituted pyridazines as EGFR and/or KRAS inhibitors (2017-02-07),

3. 8815906 - Tyrosine kinase inhibitors (2014-08-26),

4. 8629147 - Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders (2014-01-14),

5. 8063225 - Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders (2011-11-22),

6. 7645785 - Benzimidazole derivatives (2010-01-12),

7. 7335687 - 2,3-Oxidosqualene-lanosterol cyclase inhibitors (2008-02-26),

8. 7189756 - Pyrrolidine derivatives (2007-03-13),

9. 7102007 - Dihydroindole and tetrahydroquinoline derivatives (2006-09-05),

10. 7071212 - N-(4-carbamimidoyl-phenyl)-glycine derivatives (2006-07-04),

11. 6964974 - 2,3-oxidosqualene-lanosterol cyclase inhibitors (2005-11-15),

12. 6858651 - 2,3-oxidosqualene-lanosterol cyclase inhibitors (2005-02-22),

13. 6790860 - Pyrrolidine derivatives (2004-09-14),

14. 6706751 - Dihydroindole and tetrahydroquinoline derivatives (2004-03-16),

15. 6683215 - N-(4-carbamimidoyl-phenyl)-glycine derivatives (2004-01-27),

Title: Alexander Chucholowski: Pioneering Inventor from San Diego

Introduction: Alexander Chucholowski is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Alexander Chucholowski holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Chucholowski has worked with leading research institutions and tech companies, consistently pushing the boundaries of what is possible in the world of inventions.

Collaborations: Throughout his career, Alexander Chucholowski has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Alexander Chucholowski's passion for innovation and his relentless drive to create solutions for the future make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.